Functional Nanorealgar Quantum Dots with Aggregation-Induced Emission Enhancement for Tumor Neovascular-Targeted Theranostics

Figure 4

(a) CCK-8 assay of 4T1 cells treated with NR@RGD QDs at different concentrations for 24 hr; (b) CLSM images of DAPI-stained 4T1 cells after being treated with NR@RGD QDs (1.0 μg of As·mL⁻¹); (c) apoptosis/necrosis rate; (d) cell cycle distribution of 4T1 cells after being treated with NR@RGD QDs detected by IFC (1.0 μg of As·mL⁻¹).

(a)

(b)

(c)

(d)